Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What a POS dumps off news. How much did this inept management team dilute to pay Judy.
Mistake on OTC status but it's coming,and we will fly again.
Looks like we're moving through some overhead resistance before the next leg up over 0.04.The best is yet to come.
Looks like she's setting up for a push over 0
04.
I’m ready for the .04-.06 range this week. ;)
Until they drop the next bomb of a news release that brings it back to .01
They’ve been saying they were going to sell CPAP machines for over 2 years, yet haven’t, zero sales. Even tossed up a website to help the pumpers pump, and all they sold was more shares. Further, even in their most recent PR they didn’t claim to have either revenue or positive cashflow, just that they were going to “transition” from a pre-revenue company - ie - fixin to get ready to prepare to possibly start making money.
All they’ve had for years and years is that one horribly designed mask they’ve not gotten approval to sell, and even if they did, people will not buy it over the far more comfortable and established alternatives from real companies. They’ve sold enough stock to live off of for years, paying themselves handsomely.
If somebody were to say they don’t have revenue or positive cash flow my response would be you are wrong. If you were to say in the past then I would say you are correct. They were a pre-revenue company and only recently started selling CPAP machines. August 15th 10q filing will show the actual sales and revenues of these machines.
If you do next level research other then just reading the filings you would be able to read the revenues and positive cash flow statements within the Recent Press Releases
They are not cash flow positive by any stretch of the OTC's imagination. Only thing they've sold is stock, zero revenue on years of disclosures and still on their last one.
17.54% a day keeps the haters away!!! Let’s continue this 3 day green streak tomorrow!
1 Day 17.54%
1 Week 19.22%
1 Month 97.06%
3 Month 63.41%
6 Month 43.16%
Year to Date 159.69%
1 Year 229.43%
Since December 7, 2020 up a total of 2,292.86%
Learn to Ride the Waves!
Block out the noise and the nonsense
RMSL is a very real company with real products not some pump and dump hype ticker.
There is a 100% Valid US Patent for the “DeltaWave”
They successfully uplisted to OTCQB Status.
$4 million in cash and hand and are now revenue generating with positive cash flows after being a pre-revenue company
3 total mask the DeltaWave and a second mask with an unknown name but one that will have 2 versions (residential and hospital)
Do your own DD and validate the facts.
Keep in mind hater are going to hate and the date is 7.14.22 not 2013-2017 and the past led to the present status but the past is the past as stated before Debt free and many catalyst to look forward too!
Absurdly overvalued. It's been pumped on StockTwits to newbies who have zero clue of the history of the company.
BS. 80% of the claims were rejected/withdrawn and CEO has a Hail-Mary-Pass on the rejected claims in the form a NEW PATENT APPLICATION that he thus far has failed to disclose to shareholders.
You think the big boys are going to "buyout" a company whose flagship product is so unoriginal that 80% of their patent claims are worthless? Not to mention the device has failed to receive FDA clearance for the last SEVEN YEARS.
And yet they have a $50 M market cap. Very strange.
The official US patent has been shared many times and is valid for 20 years. In order for a patent to be handed out it must be determined that there is a significant difference to current patented products that make a device their own.
In this case the patent office agreed and approved the 20 Year US patent. Sure not every claim on original application was patented… but you would be a fool to not include it in your application.
I encourage people to take a look at other patents in the industry and review the process they went through as well. Just like FDA approval they all had changes that needed to be done from their original patent applications.
Trademark for “DeltaWave” has officially been applied for.
This stock really confounds me. It is one of the few OTC stocks that has maintained a fairly high amount of volume over the past year and a half compared to most of the OTC, and it has also held its price fairly well considering the fact that they are still having issues getting their products to market....which has been on ongoing theme of this company for years now. And it isn't like you see this stock pumped a lot on this board or any other stock message boards. It is fairly under the radar in that regard.
But here it sits, with a $40 M market cap and volume in the millions everyday.
It really makes no sense to me but it is what it is.
CEO misled shareholders to believe DeltaWave is fully-patented.
RMSL tweeted 4/08/21 that Utility patent would be issued 4/27/21 which gave shareholders the impression that there is a full patent on the DeltaWave. There has been NO DISCLOSURE that there is a NEW PATENT APPLICATON for the rejected patent claims on the DeltaWave.
The Press Release yesterday finished with the Sentence “This is just the beginning so stay tuned.” Well I hope you are tuned in now. I didn’t see one person talking about trademark as a future catalyst or accomplishment.
Remsleep continues to surprise me with their open communication to investors and it’s very rare to find a growing company who recognizes they wouldn’t be were they are without their shareholders and investors.
Proud to be a part of something bigger then just money. Part of a team and part of a company that is going to make a major difference in effectively treating those with sleep apnea specifically those who suffer from COPD and Congestive Heart Failure.
Sometimes it’s about more then just money and when you find that hang on tight!
Pumpers are full of it....all there for public-viewing if anyone took two minutes to look it up.
Patent was issued and finalized April 27 2021 for the Deltawave mask. A copy of the patent can easily be found.
Any other nonsense is false. There are no “new” patents.
Uplisting Press Release yesterday.
Otcqb status expected to be live tomorrow.
Remsleep released a tweet today informing investors that they have applied for trade mark on their DeltaWave!
More to come so stay tuned!
Remsleep Holdings Inc
@RemsleepInc
In anticipation of marketing and market protection, RemSleep’s trademark application for “DeltaWave” was filed with the United States Patent and Trademark Office on July 5, 2022. The USPTO has now assigned Trademark Serial No. 97489045 to the application. $RMSL
10:27 AM · Jul 13, 2022·Twitter for Androi
The Press Release yesterday finished with the Sentence “This is just the beginning so stay tuned.” Well I hope you are tuned in now. I didn’t see one person talking about trademark as a future catalyst or accomplishment.
Remsleep continues to surprise me with their open communication to investors and it’s very rare to find a growing company who recognizes they wouldn’t be were they are without their shareholders and investors.
Proud to be a part of something bigger then just money. Part of a team and part of a company that is going to make a major difference in effectively treating those with sleep apnea specifically those who suffer from COPD and Congestive Heart Failure.
Sometimes it’s about more then just money and when you find that hang on tight!
Guy claims Patent isn’t real is he gonna try and claim the uplisting isn’t real as well
RemSleep Holdings Inc. (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, announced today that the company has officially received approval to be uplisted to OTCQB® status with . We anticipate OTCQB® status to be live on within 24-48 hours of this press release. The move to the OTCQB® exchange provides enhanced investor benefits, including higher reporting standards, greater access to analyst coverage and news outlets, increased liquidity and stability, along with more comprehensive compliance requirements. The OTCQB® exchange is considered by the Securities and Exchange Commission (SEC) as an "established public market" for determining the public market price when registering securities for resale with the SEC. The OTC Pink is not considered as such, and because of this most broker dealers will not trade or recommend OTC Pink stocks. By gaining OTCQB® status, a company dramatically increases their transparency, reporting standards, and management certification and compliance requirements, therefore most broker dealers trade stocks on the OTCQB® exchange. Historically, companies that have made it to the OTCQB® tier have experienced increased investor awareness and greater liquidity and visibility of their common stock.
“This is a great milestone for RemSleep and our shareholders. We could not be more excited for where we are currently positioned and the trajectory of where we are going. Uplisting to OTCQB® status provides next level accountability from us as a company with higher reporting standards and more comprehensive compliance requirements. OTCQB® status will assist our company in providing greater shareholder value by allowing us to achieve greater market visibility, expand our potential prospective investor pool, greater share price stability, along with increased trading liquidity within the investment community. We look forward to broadening our company exposure to a larger and more diverse demographic of both domestic and international investors,” stated Tom Wood, RemSleep CEO.
Wood continued, “This is the first of many milestones we have in the works. We hope to provide an update in the next couple of weeks regarding our impending FDA 510k filing for our patented DeltaWave Nasal Pillow Mask, the filing of future 510k application(s) for our recently announced second CPAP mask that will include both a residential and hospital version, and our CPAP machine distribution deal progress. This is an exciting time for everyone involved in RemSleep as we transition from a pre-revenue OTC Pink company to a positive cash flow and profitable OTCQB® listed company. This is just the beginning so stay tuned.”
About RemSleep Holdings Inc.
www.remsleep.comRemSleep Holdings Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the RemSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea.
https://twitter.com/RemsleepInc
Team Gaslighting: "20% percent is the same as 100%!"
Keep mentioning irrelevant information. There is a very real 20 year U.S. patent and uplisting is coming any day. Debt free positive cash flows!!!
The Deltawave is revolutionary and I personally use it… this is as legit a Company as you will find in the otc world!
True growth Company
Whoops meant for whsi board
Heavy what? Lol there is no volume at all… buy sell no trade data…
Very heavy buy volume today.This company didn't come this far to fail most people know this.
It hasn’t happened yet. The Conakry is working with a testing company TBA in order to get things completed properly to submit a new 510k application for the reclassification
Man I don’t know how much you get paid but you filed to acknowledge the mask is real and works…
The Os was increased to pay for FDA process and pay off debt…
Conveniently left out that the SP continues higher and that they have mentioned a second mask in their PRs
Followers
|
309
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |